Amneal Pharmaceuticals Inc
NYSE:AMRX
Amneal Pharmaceuticals Inc
NYSE:AMRX
Price:
6.87 USD
0.29%
Market Closed
Updated:
May 16, 2024
Amneal Pharmaceuticals Inc
Non-Reccuring Items
|
Amneal Pharmaceuticals Inc
Non-Reccuring Items Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amneal Pharmaceuticals Inc
NYSE:AMRX
|
Non-Reccuring Items
-$70.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
26%
|
CAGR 10-Years
-9%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Non-Reccuring Items
-$4.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-23%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Non-Reccuring Items
-$15.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
-44%
|
|
|
Pfizer Inc
NYSE:PFE
|
Non-Reccuring Items
-$14B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-25%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Non-Reccuring Items
-$2.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-2%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Non-Reccuring Items
-$3.9B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-35%
|
See Also
What is Amneal Pharmaceuticals Inc's Non-Reccuring Items?
Non-Reccuring Items
-70.5m
USD
-70.5m
USD
Based on the financial report for Dec 31, 2023, Amneal Pharmaceuticals Inc's Non-Reccuring Items amounts to -70.5m USD.
What is Amneal Pharmaceuticals Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
-9%
-9%
Over the last year, the Non-Reccuring Items growth was 76%. The average annual Non-Reccuring Items growth rates for Amneal Pharmaceuticals Inc have been -9% over the past three years , 26% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
